Lifecare ASAOSL:LIFE -0.72%9 PS Ratio is 138.00 as of Jul. 12, 2026, which is 22% above its 10-year median of 112.85. GuruFocus rates OSL:LIFE with a GF Score™ of 9/100 and a GF Value™ of kr0.14 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Lifecare ASA ranks worse than 97.39% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Lifecare ASA's share price is kr0.276.
Lifecare ASA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.00. Hence, Lifecare ASA's PS Ratio for today is 138.00.
The historical rank and industry rank for Lifecare ASA's PS Ratio or its related term are showing as below:
OSL:LIFE'
s PS Ratio Range Over the Past 10 Years
Min: 31.78 Med: 112.85 Max: 388.37
Current: 138
During the past 11 years, Lifecare ASA's highest PS Ratio was 388.37. The lowest was 31.78. And the median was 112.85.
OSL:LIFE's PS Ratio is ranked worse than 97.39% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs OSL:LIFE: 138.00
Lifecare ASA revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Lifecare ASA was -96.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -80.10% per year.
During the past 11 years, Lifecare ASA's highest 3-Year average Revenue per Share Growth Rate was -80.10% per year. The lowest was -80.10% per year. And the median was -80.10% per year.
Back to Basics: PS Ratio
Lifecare ASA (OSL:LIFE) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Lifecare ASA PS Ratio Related Terms
Lifecare ASA PS Ratio Historical Data
* Premium members only.
The historical data trend for Lifecare ASA's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lifecare ASA's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecare ASA PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's PS Ratio distribution charts can be found below:
* The bar in red indicates where Lifecare ASA's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Lifecare ASA's PS Ratio for today is calculated as
Lifecare ASA's Share Price of today is kr0.276. Lifecare ASA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Lifecare ASA (OSL:LIFE) has a PS Ratio of 138.00 as of Jul. 12, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Lifecare ASA and its competitors. This is 22% above median its historical median of 112.85. Over the past decade, Lifecare ASA's PS Ratio has ranged from 31.78 to 388.37. According to the industry distribution chart, Lifecare ASA ranks #784 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 97.4%.
Is Lifecare ASA's PS Ratio too high?
Lifecare ASA's current PS Ratio of 138.00 is 22% above median its 10-year median of 112.85. Over the past 10 years, this metric has ranged from a low of 31.78 to a high of 388.37. The Medical Devices & Instruments industry median PS Ratio is 2.94. Lifecare ASA's value of 138.00 is 4593.9% above this industry median. Based on the distribution chart, Lifecare ASA ranks #784 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lifecare ASA has a GF Score™ of 9/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lifecare ASA's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lifecare ASA ranks #784 out of 805 companies for PS Ratio. This places Lifecare ASA in the lower half of its industry. The industry median PS Ratio is 2.94. Lifecare ASA's value of 138.00 is 4593.9% above this benchmark. Historically, Lifecare ASA's own PS Ratio has ranged from 31.78 to 388.37 over the past decade. While the company's 10-year median is 112.85 vs. the industry median of 2.94, Lifecare ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lifecare ASA's current PS Ratio of 138.00 is 4593.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Lifecare ASA and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifecare ASA's current PS Ratio is 138.00, which is 22% above median its own 10-year median of 112.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecare ASA stock overvalued right now?
Based on GuruFocus' analysis, Lifecare ASA (OSL:LIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.14, compared to a current price of kr0.28 — trading 97.1% above its estimated fair value. The current PS Ratio is 138.00, which is 22% above median its 10-year median of 112.85 and 4593.9% above the Medical Devices & Instruments industry median of 2.94. Lifecare ASA's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Lifecare ASA (OSL:LIFE), the current PS Ratio is 138.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifecare ASA (OSL:LIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Lifecare ASA stock appears to be overvalued.
The current stock price of kr0.28 is trading 97.1% above its estimated GF Value™ of kr0.14.
GuruFocus considers Lifecare ASA to be Significantly Overvalued.
Key valuation signals for OSL:LIFE:
PS Ratio: 138.00 (22% above median its 10-year median of 112.85)
GF Value™: kr0.14 vs. price of kr0.28 (97.1% above fair value)
Industry Position: 4593.9% above the Medical Devices & Instruments median (#784 of 805)
No single metric tells the full story. See the OSL:LIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
9GF Score
Get the complete analysis for OSL:LIFE
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:LIFE has been successfully added to your 
